prograf 0.5 mg
astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 0.5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.
hyoscine hydrobromide martindale pharma 600 micrograms/ml solution for injection
martindale pharmaceuticals ltd - hyoscine hydrobromide - solution for injection - 600 microgram(s)/millilitre - other antiemetics
desloratadine 0.5 mg/ml oral solution
rosemont pharmaceuticals ltd - desloratidine - oral solution - 0.5 mg/ml - other antihistamines for systemic use - antihistamines – h1 antagonist - it is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with: allergic rhinitis, urticaria
amlodipine 2mg/ml oral solution
rosemont pharmaceuticals ltd - amlodipine - oral solution - 2 mg/ml - calcium channel blockers, selective calcium channel blockers with mainly vascular effects - hypertension; chronic stable angina pectoris; vasospastic (prinzmetal's) angina
amlodipine 1mg/ml oral solution
rosemont pharmaceuticals ltd - amlodipine - oral solution - 1mg/ml - calcium channel blockers, selective calcium channel blockers with mainly vascular effects - hypertension; chronic stable angina pectoris; vasospastic (prinzmetal's) angina
methotrexate
rosemont pharmaceuticals ltd - methotrexate disodium - oral solution - 2 mg/ml - methotrexate - antineoplastic and immunomodulating agents, antimetabolites, folic acid analogues - it is indicated in the following oncological indications: the maintenance treatment of acute lymphocytic leukaemia (all) in children and adults; the treatment of malignant trophoblastic tumours and for the treatment of severe active rheumatoid arthritis in adults and the treatment of severe forms of psoriasis vulgaris including chronic plaque psoriasis, erythrodermic psoriasis, psoriatic arthritis and pustular psoriasis which are not responsive to other conventional therapies such as phototherapy, puva and retinoids.
perizam 1mg/ml oral suspension
rosemont pharmaceuticals ltd - clobazam - oral suspension - 1 milligram(s)/millilitre - benzodiazepine derivatives; clobazam - anxiolytics - it is indicated in adults for the short-term symptomatic treatment (2-4 weeks) only of anxiety that is severe, disabling or subjecting the individual to unacceptable distress. in treatment of anxiety states associated with affected disorders, perizam must only be used in conjunction with adequate treatments for the underlying disorder. in patients with schizophrenic or other psychotic illnesses, use of benzodiazepines is recommended only for short term symptomatic management of hyperarousal and agitation. benzodiazepines do not possess antipsychotic properties. perizam may be used as adjunctive therapy in epilepsy in adults or children over 6, if standard treatment with one or more anticonvulsants has failed.
perizam 2mg/ml oral suspension
rosemont pharmaceuticals ltd - clobazam - oral suspension - 2 milligram(s)/millilitre - benzodiazepine derivatives; clobazam - anxiolytics - it is a 1,5-benzodiazepine indicated in adults for the short-term symptomatic treatment (2-4 weeks) only of anxiety that is severe, disabling or subjecting the individual to unacceptable distress. in treatment of anxiety states associated with affected disorders, perizam must only be used in conjunction with adequate treatments for the underlying disorder. in patients with schizophrenic or other psychotic illnesses, use of benzodiazepines is recommended only for short term symptomatic management of hyperarousal and agitation. benzodiazepines do not possess antipsychotic properties. perizam may be used as adjunctive therapy in epilepsy in adults or children over 6, if standard treatment with one or more anticonvulsants has failed.
desloratadine 0.5mg/ml oral solution
rosemont pharmaceuticals ltd - desloratadine - oral solution - 0.5mg/ml - antihistamines – h1 antagonist - it is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with: - allergic rhinitis - urticaria
flucloxacillin vale pharmaceuticals 250 milligram pdr for soln inj/inf
vale pharmaceuticals ltd - flucloxacillin sodium - pdr for soln inj/inf - 250 milligram - beta-lactamase resistant penicillins